VolumeVol. 59 • Number No. 4 • October - December 2021 Back

Original Article

Meta-analysis on the Role of Pregabalin in Fibromyalgia

Authors: Andri Reza Rahmadi, Guntur Darmawan, Laniyati Hamijoyo

DOI: 10.65564/pjim.10e3a93bbd

Date of Publication: December 2021


Abstract

Background: Fibromyalgia is a difficult-to-treat chronic musculoskeletal pain and tenderness syndrome. It is considered due to augmented pain processing in central nervous system. Interest in antiepileptic drugs, included pregabalin, for treatment of fibromyalgia is currently growing. This study aimed to investigate the effectiveness of pregabalin for fibromyalgia.

Methods: We conducted the study according to the meta-analysis PRISMA guideline. Relevant randomized controlled trials (RCTs) were identified from a search of PubMed and Cochrane databases. Quality of selected studies was assessed using Jadad score for randomized placebo-controlled trials (RCT). Primary outcome was pain score reduction (30% and 50% reduction) and secondary outcome was patient global impression of change. Statistical analysis was performed using Review Manager 5.3.

Results: Six international, multicenter, high-quality RCTs with 8-15 weeks duration of treatment met inclusion criteria. Four studies used different fixed dose (300 mg/d, 450 mg/d, 600mg/d) and 2 studies used titrated dose in evaluating the efficacy of pregabalin. There was statistically significant benefit of pregabalin over placebo in mean pain score reduction [odds ratio (OR) 1.81, 95% confidence interval (CI) 1.56-2.10 p < 0.00001 in fixed dose pregabalin 30% pain reduction; OR 2.06 95% CI 1.66-2.56 p < 0.00001 in fixed dose pregabalin 50% pain reduction; OR 1.53 95% CI 1.10-2.13 p 0.01 in titrated dose pregabalin 30% pain reduction; OR 1.80 95% CI 1.12-2.88 p 0.01 in titrated dose pregabalin 50% pain reduction]. Pregabalin also demonstrated significantly better patient global impression of change than placebo. No heterogeneity was seen in most groups. No publication bias was observed.

Conclusion: Our study showed pregabalin monotherapy was effective for pain treatment associated with fibromyalgia. Further studies with longer treatment duration are needed to confirm the long-term effectiveness of pregabalin for fibromyalgia treatment.

Keywords: Fibromyalgia, pregabalin, meta-analysis

 


References

  1. L. M. Arnold, D. L. Goldenberg, S. B. Stanford, J. K. Lalonde, H. Sandhu, P. E. Keck, et. al. (2007). Gabapentin in the treatment of fibromyalgia: A randomized, double-blinded, placebo-controlled, multicenter trial. Arthritis & Rheumatology. 56(4): 1336-44.
  2. L. M. Arnold, I. J. Russell, E. Diri, W. R. Duan, J. P. Young, U. Sharma, et. al. (2008). A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. The Journal of Pain. 9(9): 792-805.
  3. B. Walitt, R. L. Nahin, R. S. Katz, M. J. Bergman, F. Wolfe. (2015). The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PloS one. 10(9): e0138024
  4. L. P. Queiroz. Worldwide epidemiology of fibromyalgia. (2013). Current Pain and Headache Reports. 17(8):356.
  5. L. J. Crofford, M. C. Rowbotham, P. J. Mease, I. J. Russell, R. H. Dworkin, A. E. Corbin, et. al. (2005). Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blinded, placebo-controlled trial. Arthritis & Rheumatology. 52(4):1264-73.
  6. D. J. Clauw. (2014). Fibromyalgia: A clinical review. JAMA. 311(15):1547-55.
  7. D. L. Goldenberg, C. Burckhardt, L. Crofford. (2004). Management of fibromyalgia syndrome. JAMA. 292(19): 2388-95.
  8. L. M. Arnold, P. Arsenault, C. Huffman, J. L. Patrick, M. Messig, M. L. Chew, et. al. (2014). Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: A phase III, double-blind, randomized withdrawal, placebo-controlled study. Current Medical Research and Opinion. 30(10):2069-83.
  9. P. J. Mease, I. J. Russell, L. M. Arnold, H. Florian, J. P. Young, S. A. Martin, et. al. (2008). A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. The Journal of Rheumatology. 35 (3):502-14.
  10. H. Ohta, H. Oka, C. Usui, M. Ohkura, M. Suzuki, K. Nishioka. (2012). A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia. Arthritis research & therapy. 14(5):217.
  11. L. Pauer, A. Winkelmann, P. Arsenault, A. Jespersen, L. Whelan, G. Atkinson, et. al. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. (2011). The Journal of Rheumatology.2:
  12. T. Tzellos, K. Toulis, D. Goulis, G. Papazisis, V. Zampeli, A. Vakfari, et. al. (2010). Gabapentin and pregabalin in the treatment of fibromyalgia: A systematic review and a meta-analysis. Journal of Clinical Pharmacy and Therapeutics. 35(6):639-56.
  13. P. J. Wiffen, S. Derry, R. A. Moore, D. Aldington, P. Cole, A. S. C. Rice, et. al. (2013). Antiepileptic drugs for neuropathic pain and fibromyalgia: An overview of Cochrane reviews. Cochrane Database Syst Rev. 11: CD010567.
  14. Y. H. Lee, G . G. Song. (2016). Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: A Bayesian network meta-analysis of randomized controlled trials. Rheumatology International. 36(5):663-72.
  15. R. A. Moore, S. Straube, P. J. Wiffen, S. Derry, H. J. McQuay. (2009) Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 8(3): CD007076.
  16. C. E. Argoff, B. Emir, E. Whalen, M. Ortiz, L. Pauer, A. Clair. (2016). Pregabalin improves pain scores in patients with fibromyalgia irrespective of comorbid osteoarthritis. Pain Medicine. 17 (11): 2100-8.
  17. S. Straube, R. A. Moore, J. Paine, S. Derry, C. J. Phillips, E. Hallier, et. al. (2011). Interference with work in fibromyalgia-effect of treatment with pregabalin and relation to pain response. BMC Musculoskeletal Disorders. 12 (1):125.
  18. S. Derry, M. Cording, P. J. Wiffen, S. Law, T. Phillips, Moore RA. (2016). Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 9(9): CD0011790.
  19. S. Straube, S. Derry, R. A. Moore, H. J. McQuay. (2010). Pregabalin in fibromyalgia: Meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology. 49(4):706-15.